Upstream Bio, Inc. (($UPB)) announced an update on their ongoing clinical study. Upstream Bio, Inc. is conducting a study titled ‘A Long-Term ...
Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...
Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...
Mepolizumab significantly reduced healthcare resource utilization, including hospitalizations and emergency department visits, in patients with severe eosinophilic asthma over two years. The treatment ...
Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during ...
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...
The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.
Abstract: This study presents a system using Long-short-term memory (LSTM) network for asthma disease prediction from respiratory dataset. For neural network training, a total of 34,000 respiratory ...
Inhalers that provide fast-acting treatment for people with certain respiratory conditions are contributing to greenhouse gas emissions, which can worsen both climate change and the conditions ...
Scientists have discovered a link between food additives and immune pathways in children, suggesting they could play a part in triggering childhood asthma. They have singled out sweeteners, colourants ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback